BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7572577)

  • 1. Endogenous tissue plasminogen activator and platelet reactivity as risk factors for reocclusion after recanalization of chronic total coronary occlusions.
    Terres W; Lund GK; Hübner A; Ehlert A; Reuter H; Hamm CW
    Am Heart J; 1995 Oct; 130(4):711-6. PubMed ID: 7572577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of a prothrombotic state in restenotic patients?
    Brack MJ; More RS; Pringle S; Gershlick AH
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
    Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
    Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
    Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
    Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA.
    Benedict CR; Refino CJ; Keyt BA; Pakala R; Paoni NF; Thomas GR; Bennett WF
    Circulation; 1995 Nov; 92(10):3032-40. PubMed ID: 7586274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
    Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
    Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
    Nordt TK; Moser M; Kohler B; Ruef J; Peter K; Kübler W; Bode C
    Thromb Haemost; 1998 Dec; 80(6):881-6. PubMed ID: 9869154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with low-dose intracoronary recombinant tissue-type plasminogen activator for nonacute total occlusions before percutaneous transluminal coronary angioplasty.
    Ruocco NA; Currier JW; Jacobs AK; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Dec; 68(17):1609-13. PubMed ID: 1746461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recanalization of chronic coronary artery occlusions using laser followed by balloon angioplasty.
    Schofer J; Kresser J; Rau T; Kunze KP; Kühn CR; Mathey DG
    Am J Cardiol; 1996 Oct; 78(7):836-8. PubMed ID: 8857495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.
    Alexandrov AV; Grotta JC
    Neurology; 2002 Sep; 59(6):862-7. PubMed ID: 12297567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion.
    Yao SK; McNatt J; Anderson HV; Eidt J; Cui KX; Golino P; Glas-Greenwalt P; Maraganore J; Buja LM; Willerson JT
    Am J Physiol; 1992 Feb; 262(2 Pt 2):H374-9. PubMed ID: 1539695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary coronary stenting after successful balloon angioplasty of chronic total occlusions: a single-center experience.
    Suttorp MJ; Mast EG; Plokker HW; Kelder JC; Ernst SM; Bal ET
    Am Heart J; 1998 Feb; 135(2 Pt 1):318-22. PubMed ID: 9489982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors.
    Haskel EJ; Adams SP; Feigen LP; Saffitz JE; Gorczynski RJ; Sobel BE; Abendschein DR
    Circulation; 1989 Dec; 80(6):1775-82. PubMed ID: 2513145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of collateral function after recanalization of chronic total coronary occlusions: a serial assessment by intracoronary pressure and Doppler recordings.
    Werner GS; Emig U; Mutschke O; Schwarz G; Bahrmann P; Figulla HR
    Circulation; 2003 Dec; 108(23):2877-82. PubMed ID: 14623811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SC-49992, a mimetic of the peptide arginine-glycine-aspartic acid-phenylalanine that blocks platelet aggregation, enhances recombinant tissue plasminogen activator-induced thrombolysis and prevents reocclusion in a canine model of coronary artery thrombosis.
    Feigen LP; Nicholson NS; King LW; Campion JG; Tjoeng FS; Panzer-Knodle SG
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1191-7. PubMed ID: 8263779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible mechanism of vascular reocclusion after initially successful thrombolysis with recombinant tissue-type plasminogen activator.
    Yamada Y; Furui H; Furumichi T; Yamauchi K; Yokota M; Saito H
    Am Heart J; 1991 Jun; 121(6 Pt 1):1618-27. PubMed ID: 1903579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.
    Yasuda T; Gold HK; Fallon JT; Leinbach RC; Guerrero JL; Scudder LE; Kanke M; Shealy D; Ross MJ; Collen D; Coller BS
    J Clin Invest; 1988 Apr; 81(4):1284-91. PubMed ID: 2832448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin activation system in restenosis: role in pathogenesis and clinical prediction?
    Christ G; Kostner K; Zehetgruber M; Binder BR; Gulba D; Huber K
    J Thromb Thrombolysis; 1999 Jun; 7(3):277-85. PubMed ID: 10375389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.